Join to access to all OVN content. Join for Free
Power of Podcasts: 3 Surprising Ways MSLs can Level Up By Tuning In
Medical Science Liaisons MSL career development podcasts for MSLs professional growth networking with KOLs

Power of Podcasts: 3 Surprising Ways MSLs can Level Up By Tuning In


Share This Article


Summary

In this episode, Sarah Snyder, MSL Recruiter with The Carolan Group, joins to discuss the impactful role of podcasts in the career development of Medical Science Liaisons. The conversation highlights why MSLs should actively engage with podcasts, utilizing them for professional growth and staying informed. Sarah shares tips on discovering and connecting with relevant podcasts and opinion leaders, emphasizing the importance of exploring various genres for both personal and professional interests. The episode concludes with a discussion on the accessibility and benefits of podcasting for MSLs, along with final thoughts and summer plans.

Sarah Snyder, Associate Director, Medical Affairs at Biosplice Therapeutics discusses the power of Podcasts and 3 Surprising ways MSLs can Level up by tuning In.

Sarah shares….

πŸ‘‰ Why MSLs should be listening to podcasts

πŸ‘‰ What podcasts she recommends and why

πŸ‘‰ How podcasts can help with networking and KOL development

πŸ‘‰ How to find therapeutic area podcasts

πŸ‘‰ Podcasts for personal development

Click for Source
Medical Science Liaisons, MSL career development, podcasts for MSLs, professional growth, networking with KOLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Freedom: The Mid Year Check In
Partner Avatar MSL Talk: Tom Caravela

Freedom: The Mid Year Check In

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Explore OVN